A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)
Clinical trial NCT05532046 · TERMINATED
Trial details
- NCT number
- NCT05532046
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-20
- Primary completion
- 2023-03-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.